Sinclair IS Pharma Plc Stock Rating Reaffirmed by Canaccord Genuity (SPH)
Sinclair IS Pharma Plc (LON:SPH)‘s stock had its “buy” rating reaffirmed by stock analysts at Canaccord Genuity in a report issued on Tuesday, American Banking News.com reports. They currently have a GBX 38 ($0.62) price target on the stock. Canaccord Genuity’s price objective indicates a potential upside of 35.71% from the stock’s previous close.
Sinclair IS Pharma Plc (LON:SPH) traded up 12.43% during mid-day trading on Tuesday, hitting GBX 31.62. The stock had a trading volume of 1,932,085 shares. Sinclair IS Pharma Plc has a 52-week low of GBX 23.15 and a 52-week high of GBX 33.50. The stock’s 50-day moving average is GBX 29.51 and its 200-day moving average is GBX 28.24.
A number of other firms have also recently commented on SPH. Analysts at FinnCap reiterated a “buy” rating on shares of Sinclair IS Pharma Plc in a research note to investors on Tuesday. They now have a GBX 40 ($0.66) price target on the stock. Separately, analysts at Nplus1 Brewin reiterated a “buy” rating on shares of Sinclair IS Pharma Plc in a research note to investors on Tuesday. They now have a GBX 36 ($0.59) price target on the stock. Finally, analysts at Investec upgraded shares of Sinclair IS Pharma Plc to a “buy” rating in a research note to investors on Tuesday. They now have a GBX 38 ($0.62) price target on the stock. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of GBX 65.22 ($1.07).
Sinclair IS Pharma plc is a specialty pharmaceutical company focused on treatments in dermatology, wound care, oncology support and critical care through surface technology and delivery systems.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.